J Korean Assoc Oral Maxillofac Surg.  2004 Apr;30(2):136-142.

Intraarterial chemotherapy of malignant fibrous histiocytoma(MFH) in the maxilla: A clinical case

Affiliations
  • 1Department of Oral & Maxillofacial Surgery, Korea Cancer Center Hospital, Korea. moge88@hanmail.net

Abstract

Malignant fibrous histiocytoma(MFH) is the malignant part of mesenchymal cell-originated tumor, which is supposed that the tumor is presented various histologic features consisted of fibrosarcomatic and histiocytic portions. When the tumor is arisen in the head and neck region, the most affected sites are the nasal cavity and paranasal sinuses, and secondly the maxillary alveolar bone is occasionally influenced. Therefore, MFH can readily involve the adjacent alveolar bone. The treatment of MFH in the head and neck is various, that is, the involved sites and the differentiation of tumor must be considered when the tumor is treated. The treatment protocols are subjected to general ones of soft tissue sarcoma, and simple or combination therapy is used in the surgery, chemotherapy and radiation therapy. So, we report a clinical case of chemotherapy involving intraarterial chemotherapy, and surgery of malignant fibrous histiocytoma(MFH) in the maxilla, with review of the literature.

Keyword

Malignant fibrous histiocytoma(MFH); Chemotherapy

MeSH Terms

Clinical Protocols
Drug Therapy*
Head
Maxilla*
Nasal Cavity
Neck
Paranasal Sinuses
Sarcoma
Full Text Links
  • JKAOMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr